Haloprogin for tinea.
D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003365:Costs and Cost Analysis; D006118:Griseofulvin / Q000627:therapeutic use; D006801:Humans; D006920:Hygiene; D010636:Phenols / Q000627:therapeutic use*; D010647:Phenyl Ethers / Q000627:therapeutic use; D011196:Potassium Permanganate / Q000627:therapeutic use; D012008:Recurrence; D014005:Tinea / Q000188:drug therapy*; D014008:Tinea Pedis / Q000188:drug therapy / Q000517:prevention & control; D014047:Tolnaftate / Q000627:therapeutic use
D000935:Antifungal Agents; D010636:Phenols; D010647:Phenyl Ethers; D011196:Potassium Permanganate; D014047:Tolnaftate; D006118:Griseofulvin